FAKTOR OPTIONSSCHEIN - AMGEN | Delayed Deutsche Boerse AG 08:25:56 2024-06-24 EDT | ||
| 2.21 EUR | -0.90% |
|
| Current month | -3.04% | ||
| 1 month | +4.69% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-24 | 2.21 | -0.90% |
| 24-06-21 | 2.23 | -0.45% |
| 24-06-20 | 2.24 | -0.44% |
| 24-06-19 | 2.25 | -3.02% |
| 24-06-18 | 2.32 | -1.69% |
Delayed Quote Deutsche Boerse AG
Last update June 24, 2024 at 08:25 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UL67NV |
| ISIN | DE000UL67NV8 |
| Date issued | 2023-08-10 |
| Strike | 410.9 $ |
| Maturity | Unlimited |
| Parity | 41.98 : 1 |
| Emission price | 5.2 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.94 € |
|---|---|
| Lowest since issue | 1.92 € |
| Spread | 0.1 € |
| Spread % | 4.33% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
308.2
USD
Average target price
316.4
USD
Spread / Average Target
+2.69%
- Stock Market
- Certificates
- Certificat
